@article{TumamposWulfKuehnertetal.2015, author = {Jonas Tumampos and Norbert Wulf and Helmut K{\"u}hnert and Olaf Solbrig and J{\"u}rgen Quereng{\"a}sser and Matthias Heinke}, title = {Cardiac index in atrio- and interventricular delay optimized cardiac resynchronization therapy and cardiac contractility modulation}, series = {Current Directions in Biomedical Engineering}, volume = {1}, number = {1}, publisher = {De Gruyter}, doi = {10.1515/CDBME-2015-0023}, pages = {89 -- 91}, year = {2015}, abstract = {Cardiac resynchronization therapy (CRT) is an established therapy for heart failure patients and improves quality of life in patients with sinus rhythm, reduced left ventricular ejection fraction (LVEF), left bundle branch block and wide QRS duration. Since approximately sixty percent of heart failure patients have a normal QRS duration they do not benefit or respond to the CRT. Cardiac contractility modulation (CCM) releases nonexcitatoy impulses during the absolute refractory period in order to enhance the strength of the left ventricular contraction. The aim of the investigation was to evaluate differences in cardiac index between optimized and nonoptimized CRT and CCM devices versus standard values. Impedance cardiography, a noninvasive method was used to measure cardiac index (CI), a useful parameter which describes the blood volume during one minutes heart pumps related to the body surface. CRT patients indicate an increase of 39.74 percent and CCM patients an improvement of 21.89 percent more cardiac index with an optimized device.}, language = {en} }